Geriatric Assessment of Older Patients Receiving Trabectedin in First-Line Treatment for Advanced Soft Tissue Sarcomas: The E-TRAB Study from The German Interdisciplinary Sarcoma Group (GISG-13)

Geriatric Assessment of Older Patients Receiving Trabectedin in First-Line Treatment for Advanced Soft Tissue Sarcomas: The E-TRAB Study from The German Interdisciplinary Sarcoma Group (GISG-13)

E-TRAB was a non-interventional, prospective trial investigating the feasibility and predictive value of geriatric assessments (GA) in older STS patients treated with trabectedin as first-line therapy. Primary endpoints were overall survival (OS), quality of life and individual clinical benefit asse...

Full description

Bibliographic Details
Main Authors: Bernd Kasper, Daniel Pink, Christian Rothermundt, Stephan Richter, Marinela Augustin, Attila Kollar, Annegret Kunitz, Wolfgang Eisterer, Verena Gaidzik, Thomas Brodowicz, Gerlinde Egerer, Peter Reichardt, Peter Hohenberger, Markus K. Schuler
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Cancers
Subjects:
geriatric assessment
patient-reported outcome
PRO
soft tissue sarcoma
STS
trabectedin
Online Access:https://www.mdpi.com/2072-6694/16/3/558

Internet

https://www.mdpi.com/2072-6694/16/3/558

Similar Items